Similarly, in hepatic pathology, CGA ameliorates carbon tetrachloride (CCl4)-induced liver fibrosis through selective inhibition of PI3K/AKT activation, thereby reducing extracellular matrix deposition and fibrogenic gene expression [37]. Here, AKT1 is linked to Hepatic fibrosis.